By Caitlyn Stulpin
Influenza vaccine efficacy during the 2022-2023 influenza season was “moderate” but still prevented many health care encounters and hospitalizations among adult patients, researchers determined. Read the article in Healio.
By Richard Damas
WORCESTER, Mass. – A warm welcome Sunday afternoon for Christ Jubilee International Ministry Pastor Edith Stevquoah at her home after she underwent surgery for a kidney transplant earlier this fall. Read the article in Spectrum News 1.
CONTRIBUTORS: Lena Kohlmeier,Jeannine von der Born,Elena Lehmann,Kerstin Fröde,Carl Grabitz,Anne-Sophie Greiner,Alexander A Albrecht,Nima Memaran,Rizky I Sugianto,Uwe Tegtbur,Bernhard M W Schmidt,Nele Kanzelmeyer,Anette Melk
Cardiovascular (CV) morbidity after kidney transplantation (KTx) in childhood is of increasing importance. In light of a high prevalence of CV risk factors, protective measures such as physical activity (PA) come into focus. Our aim was to comprehensively assess PA in pediatric KTx recipients and evaluate its impact on CV health. Read the article in Physician’s Weekly.
By Erin T. Welsh, MA
Compared with men, women with prediabetes may benefit from earlier intervention to prevent cardiovascular disease, according to a presenter at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease Conference. Read the article in Healio.
By Michael Monostra
The development of incretin-based molecules has led to therapies that can induce greater reductions in HbA1c and body weight for people with type 2 diabetes and obesity than other classes of medication, according to a speaker.
At the World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease, Richard E. Pratley, MD, a Healio | Endocrine Today Co-editor and the Samuel E. Crockett chair in diabetes research and medical director at AdventHealth Diabetes Institute, discussed the history of incretin-based therapies and continuing advances today. Read the article in Healio.
by Drew Remignanti, MD, MPH
“People need primary care but not necessarily a physician relationship,” said the CEO of a multibillion dollar healthcare system, with 30 years of experience in healthcare, when asked, “What’s one conviction in healthcare that needs to be challenged?”
As a physician and patient, I find this stunningly insulting and downright dangerous to hear, especially from someone with a significant influence on the future direction of U.S. healthcare. Read the article in MedPage Today.
Managing your health after transplant can feel like a full-time job, especially in the beginning. And when it comes to caring for your new kidney, medications play no small part. Taking immunosuppressant (anti-rejection) drugs keeps your transplanted organ protected and healthy. Read the article on CareDx.com.
By Andrew (Drew) Rhoades
Almost 40% of patients with type 2 diabetes stopped taking their second-line medication within 1 year, putting them at risk for future hospitalization related to diabetes, according to researchers.
Previous research has found alarming antidiabetic medication (ADM) usage trends because most adults with type 2 diabetes are eligible for GLP-1 receptor agonists and SGLT2 inhibitors but few use them. Read the article in Healio.
Advances in knowledge and techniques improved postoperative liver transplant outcomes, but optimizing re-liver transplant outcomes requires further research.
Initial liver transplant (LT) outcomes have improved over recent decades; however, liver re-transplant outcomes have not kept pace, Stanford University researchers report in Clinical Transplantation.
“Our study investigated the progress of liver re-transplant (re-LT) outcomes in the United States over the past two decades. Read the article in Physician’s Weekly.
After a lifesaving lung transplant, Glen Hohn then had a life-threatening bout of COVID-19. However, thanks to his care team and some music therapy, his lungs improved, his confidence grew and he was discharged after an extraordinary experience.
Watch this story from Nebraska Medicine.